Preclinical Development of a Bridging Therapy for Radiation Casualties

Edité par Elsevier Inc, Amsterdam [?], 2010

Partenaire historique

Vendeur : Ground Zero Books, Ltd., Silver Spring, MD, Etats-UnisGround Zero Books, Ltd.

Vendeur avec une évaluation de 5 étoiles

Vendeur AbeBooks depuis 14 août 1998

Afficher les articles de ce vendeur

Etat: Occasion - Satisfaisant

EUR 13,28

EUR 4,30 expédition 
Expédition nationale : Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier
Retours gratuits sous 30 jours

Item description from seller

Pages 61-70. Illustrations. There are six black and white graphs showing results post radiation. Minor highlighting on front page. Topics covered include Materials and Methods, Results, and References. Dr. Singh was with the Radiation Countermeasures Program and the Department of Radiation Biology at the Armed Forces Radiobiology Research Institute. Dr. Brown was also with that Department. Dr. Kao was with the Uniformed Services University of the Health Sciences. Dr. Singh's primary research interests are to develop radiation countermeasures for acute radiation syndrome (ARS). My activities for this endeavor can be divided into the following major categories: 1) Development of genistein (isoflavone - BIO 300/BIO 301) as radiation countermeasure for ARS and delayed effects of acute radiation exposure (DEARE), 2) Identification and validation of biomarkers for radiation injury and countermeasure efficacy,and 3) Advanced development of promising radiation countermeasures such as tocols, Ex-RAD, myeloid progenitors, anticeramide-antibody and other related agents. His laboratory has extensive experience in studying the effects of various radiation countermeasures on injury and recovery. His research objective is to identify and validate non-invasive biomarkers for radiation injury and countermeasure efficacy. His laboratory has identified and validated several biomarkers for radiation dose assessment and efficacy of radiation countermeasures using various omic platforms. He is the recipient of several prestigious award and serves as editorial board member for several reputed journals. This paper addressed victims of a terrorism attack presenting with the hematopoietic syndrome resulting from exposure to excessive levels of ionizing radiation will succumb to sepsis if not adequately treated. The probability of survival is increased substantially if the victim's immune system is allowed to recover before sepsis sets in. The authors report on preclinical development of a new bridging therapy that will allow victims of radiation casualties to recover from damage caused by ionizing radiation. Experimental Hematology? publishes original research reports (regular and fast-track submissions), reviews, letters to the editor, and abstracts of the annual meeting of ISEH - International Society for Experimental Hematology. We welcome manuscripts describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis as well as non-malignant hematologic diseases. Submissions focused on non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems) with potential relevance to hematopoiesis are also welcome, as are studies involving experimental or early phase clinical cell transplantation. Studies employing genomic and systems biology approaches to the study of normal and malignant hematopoiesis are strongly encouraged, as are those employing model organisms. Xerox style copy of offprint from the Society for Hematology and Stem Cells journal Experimental Hematology 2010;38;61-70.

N° de réf. du vendeur 78983

Détails bibliographiques

Titre
Preclinical Development of a Bridging Therapy for Radiation Casualties
Auteur
Singh, Vijay K., and Brown, Darren S., and Kao, Tzu-Cheg Kao, and Seed, Thomas M.
Éditeur
Elsevier Inc, Amsterdam [?]
Année de publication
2010
État de l'article
Good
Reliure
Stapled at upper left corner

Ground Zero Books, Ltd.

Silver Spring, MD, Etats-Unis

Vendeur avec une évaluation de 5 étoiles

Vendeur AbeBooks depuis 14 août 1998

Frais d'expédition à l'intérieur de ce pays : Etats-Unis

Article5 à 20 jours ouvrés3 à 6 jours ouvrés
Premier articleEUR 4,30EUR 6,45
Les délais de livraison sont fixés par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent être retardées et les acheteurs sont responsables de tous les droits ou frais associés. Les vendeurs peuvent vous contacter au sujet de frais supplémentaires afin de couvrir toute augmentation des coûts d'expédition de vos articles.

Modes de paiement

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay
  • Chèque
  • Facture
  • Mandat
  • Paypal

Description de la boutique

Founded and operated by trained historians, Ground Zero Books, Ltd., serves the book collector, the scholar, and institutions. We focus on the individual, and pride ourselves on our personal service. Please contact us with your wants, as we have many books not yet listed in our database.

Spécialité

Military History, Nuclear, American Revolution, Military Medicine, Vietnam, World War II, British Empire, World War I, Unit Histories, Civil War

Profil professionnel du vendeur

Ground Zero Books, Ltd.

9033 Georgia Avenue
Silver Spring, MD Etats-Unis 20910-2254